| 发明名称 |
FGF21 mutants and uses thereof |
| 摘要 |
Abstract The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions. |
| 申请公布号 |
AU2013211503(B2) |
申请公布日期 |
2016.03.31 |
| 申请号 |
AU20130211503 |
申请日期 |
2013.08.01 |
| 申请人 |
AMGEN INC. |
发明人 |
WALKER, KENNETH W.;GEGG JR., COLIN V.;HECHT, RANDY I.;BELOUSKI, EDWARD J.;LI, YUE-SHENG;MICHAELS, MARK L.;XU, JING;ELLISON, MURIELLE M. |
| 分类号 |
C07K14/50;A61K38/18 |
主分类号 |
C07K14/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
